181 related articles for article (PubMed ID: 14670616)
1. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
[TBL] [Abstract][Full Text] [Related]
2. The combination of Jun N-terminal kinase inhibitor and TNP-470 blocks carcinosarcoma-induced endothelial cell tube formation in a synergistic manner.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2005 Mar; 220(1):49-55. PubMed ID: 15737687
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
4. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Anticancer Res; 2000; 20(1C):601-4. PubMed ID: 10769702
[TBL] [Abstract][Full Text] [Related]
5. Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines.
Seki M; Toi M; Kobayashi K; Shitara K; Umezawa K; Seon BK; Kan M; Rhim JS
Int J Oncol; 2000 Sep; 17(3):525-33. PubMed ID: 10938394
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
7. Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenografts.
Naganuma Y; Choijamts B; Shirota K; Nakajima K; Ogata S; Miyamoto S; Kawarabayashi T; Emoto M
Cancer Sci; 2011 Aug; 102(8):1545-52. PubMed ID: 21631643
[TBL] [Abstract][Full Text] [Related]
8. TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically.
Minischetti M; Vacca A; Ribatti D; Iurlaro M; Ria R; Pellegrino A; Gasparini G; Dammacco AF
Br J Haematol; 2000 Jun; 109(4):829-37. PubMed ID: 10929037
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
14. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
Miura S; Matsuo Y; Saku K
Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
[TBL] [Abstract][Full Text] [Related]
17. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
18. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.
Zhang Y; Griffith EC; Sage J; Jacks T; Liu JO
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6427-32. PubMed ID: 10841547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
